Connection
Christopher Hoyte to Treatment Outcome
This is a "connection" page, showing publications Christopher Hoyte has written about Treatment Outcome.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.241 |
|
|
|
-
Glatstein M, Bonifacio Rino P, de Pinho S, Scolnik D, Pivko-Levi D, Hoyte C. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center. Am J Ther. 2019 May/Jun; 26(3):e344-e349.
Score: 0.063
-
Glatstein M, Adir D, Galil B, Scolnik D, Rimon A, Pivko-Levy D, Hoyte C. Pediatric jellyfish envenomation in the Mediterranean Sea. Eur J Emerg Med. 2018 Dec; 25(6):434-439.
Score: 0.061
-
Glatstein M, Carbell G, Scolnik D, Rimon A, Hoyte C. Treatment of pediatric black widow spider envenomation: A national poison center's experience. Am J Emerg Med. 2018 06; 36(6):998-1002.
Score: 0.057
-
Chua-Tuan JL, Cao D, Iwanicki JL, Hoyte CO. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report. Clin Toxicol (Phila). 2015 Jul; 53(6):565-8.
Score: 0.048
-
Srisuma S, Hoyte CO, Wongvisavakorn S, Wanaukul W. Serotonin syndrome precipitated by sertraline and discontinuation of clozapine. Clin Toxicol (Phila). 2015; 53(8):840-1.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|